Metabolic fatty liver disease
Conditions
Interventions
experimental group:Yinchenhao Decoction
control group:Nil
Sponsors
Shanghai Public Health Clinical Center
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged >= 18 years old and <= 65 years old; 2. It is in accordance with the diagnostic criteria of metabolic fatty liver disease and belongs to the syndrome differentiation standard of dampness heat in TCM; 3. The CT ratio of liver to spleen was less than or equal to 0.9; 4. If the patient is unable to sign the informed consent, the legal representative can sign on behalf of the patient; 5. ALT <= 2 ULN; AST <= 2ULN; TBiL <= 3ULN; 6. Fasting blood glucose (FPG) <= 7.0umol/l, glycosylated hemoglobin (HbA1c) <= 6.5%.
Exclusion criteria
Exclusion criteria: 1. Patients with fatty liver caused by chronic heart failure, malnutrition and pregnancy, encephalopathy fatty liver syndrome (Reye syndrome), ß - lipoprotein deficiency and localized fatty liver; fatty liver disease caused by diabetes, long-term use of hormone, small intestinal bypass surgery, toxic injury of liver cells, chronic febrile diseases such as tuberculosis, ulcerative colitis and chronic infection after gastrointestinal surgery; 2. Severe fatty liver with ascites, edema, hyponatremia and hypokalemia, hepatitis or cirrhosis caused by virus, drug poisoning and immune diseases; 3. Those who had used any traditional Chinese and Western medicine in the treatment of metabolic related fatty liver disease within 4 weeks before they were randomly enrolled; 4. Women who are not willing to take contraceptive measures, such as contraceptives, contraceptives, contraceptives, etc; 5. Patients with severe primary cardiovascular disease, liver disease, kidney disease, hematological disease, lung disease or tumor, AIDS and other serious diseases affecting survival. 6. Patients with dyslipidemia need intervention of lipid-lowering drugs; 7. Having no or limited capacity for civil conduct; 8. Those who suspected or did have alcohol (equivalent to alcohol volume >= 40g / day in male and >= 20g / day in female) and drug abuse history; 9. Those who are known to be allergic to the components of Yinchenhao Decoction; 10. Participants in other clinical trials within 3 months before the trial; 11. The researchers considered it inappropriate to participate in the experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| liver fat content; | — |
Countries
China
Contacts
Public ContactLu Yunfei
Shanghai Public Health Clinical Center
Outcome results
None listed